歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > Neuroscience > Xanomeline (oxalate)

瀏覽歷史

S83161

Xanomeline (oxalate)

源葉(MedMol) ≥98%
  • 英文名:
  • Xanomeline (oxalate)
  • 別名:
  • XANOMELINE OXALATE; UNII-JF5A0PK3G5;
  • CAS號:
  • 141064-23-5
  • 分子式:
  • C16H25N3O5S
  • 分子量:
  • 371.4518
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S83161-10mg ≥98% ¥430.00元 10 - - - EA 加入購物車
源葉(MedMol) S83161-50mg ≥98% ¥1440.00元 10 - - - EA 加入購物車
源葉(MedMol) S83161-100mg ≥98% ¥2470.00元 10 - - - EA 加入購物車
源葉(MedMol) S83161-250mg ≥98% ¥4737.00元 7 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: Xanomeline oxalate (LY246708 oxalate) is a potent and selective muscarinic receptor agonist (SMRA) and stimulates phosphoinositide hydrolysis in vivo. Xanomeline oxalate can be used for the research of Alzheimer’s disease
  • 靶點: muscarinic receptor;AChR
  • 體外研究:
    Xanomeline stimulates phosphoinositide (PI) hydrolysis in the A9 L m1 cells. Xanomeline inhibits [3H]-pirenzepine ([3H]-PZ) and [3H]-oxotremorine-M ([3H]-OXO-M) binding to rat brain with Kis of 7 and 3 nM, respectively
  • 體內(nèi)研究:
    Xanomeline robustly stimulates in vivo PI hydrolysis and the effect is blocked by muscarinic antagonists, demonstrating mediation by muscarinic receptors. In mice the ED100 for Xanomeline-induced stimulation of [3H]-IP accumulation is 54 μmole/kg in hippocampus. And in rats the ED100 for Xanomeline-induced stimulation of [3H]-IP accumulation is 8.1 μmole/kg in hippocampus. Animal Model: Male CF1 mice weighing 18-20 g are injected [3H]-myoinositol Dosage: 8.1-81 μmole/kg Administration: S.c. injections; 1 h prior to killing and 1 h after the administration Result: Increased accumulation in a dose-related manner up to 130%, 75%, 60% above lithium levels in hippocampus, cortex and neostriatum, respectively. And did not increase accumulation of [3H]-IP in the brain stem. Induced salivation, tremor and hypothermia in mice with the ED50 of 13.7±0.8 μmole/kg. Animal Model: Rats are injected [3H]-myoinositol Dosage: 2.7-81 μmole/kg Administration: S.c. injections; 1 h prior to killing and 1 h after the administration Result: Increased [3H]-IP formation dose dependently in hippocampus up to 221% above lithium control.
  • 參考文獻:
    1. F P Bymaster, et al. Xanomeline Compared to Other Muscarinic Agents on Stimulation of Phosphoinositide Hydrolysis in Vivo and Other Cholinomimetic Effects. Brain Res. 1998 Jun 8; 795(1-2):179-90.
  • 溶解性: soluble  in  DMSO
  • 保存條件: 2-8℃;充氬;干燥
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.692 ml 13.461 ml 26.921 ml
    5 mM 0.538 ml 2.692 ml 5.384 ml
    10 mM 0.269 ml 1.346 ml 2.692 ml
    50 mM 0.054 ml 0.269 ml 0.538 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。